MRLN earnings analysis
What we found in MRLN's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
Merlin’s second-quarter results showed a 29.4% year-over-year revenue decline to $2.194 million, a negative 5.4% gross margin, a negative 1,528.1% operating margin, and diluted EPS of $(1.40), materially below the $(0.25) estimate. Operating expenses continued to expand, with R&D up 139.0% to $16.387 million and G&A up 309.5% to $15.576 million, while the company used $50.896 million of operating cash in the first half. Financing raised $181.493 million and eliminated debt obligations, but persistent losses, dependence on government and aircraft-manufacturer support, and unresolved material weaknesses remain significant concerns.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Revenue declined on USSOCOM phase timing
- Second-quarter revenue was $2.194 million, down 29.4% from $3.107 million in the prior-year quarter, primarily because one USSOCOM contract phase was completed and a new phase began.
- Gross margin turned negative
- Gross profit was a loss of $119 thousand, or a gross margin of approximately negative 5.4%, versus gross profit of $41 thousand in the prior-year quarter.
- Engineering investment accelerated
- Research and development expense increased 139.0% to $16.387 million from $6.856 million, driven by engineering hiring, outside subject-matter experts, and higher equipment and material costs.
- Capital raises strengthened liquidity
- The company reported $181.493 million of financing cash inflows for the six months ended June 30, 2026, including approximately $80.0 million of gross proceeds from the May 1 private placement.
- Debt obligations were eliminated
- The company had no debt obligations as of June 30, 2026 after repaying its PGF Loan and 2021 and 2024 LSA term loans; restricted cash was $2.570 million.
- C-130J delivery milestone identified
- Management said initial customer deliveries are currently anticipated within the next year under the C-130J program, supported by an IDIQ contract with a ceiling value of up to $105 million.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Material weaknesses remain unresolved
- Management concluded that disclosure controls and procedures were not effective as of June 30, 2026 because of material weaknesses involving complex transactions, segregation of duties, and IT general controls. The weaknesses could lead to material misstatements or delayed filings.
- Aircraft data access could constrain delivery
- The filing newly highlights dependence on aircraft manufacturers for proprietary technical data, interface specifications, and software. Loss or delay of access could require costly redesign and delay or terminate programs, including work associated with the $105 million IDIQ contract.
- Large losses and cash burn require funding
- The company used $50.896 million in operating cash during the first six months of 2026 while reporting a $148.846 million net loss. Management expects losses to continue for the next few years and said additional equity or debt financing may be required.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $-1.4
- Gross margin
- -5.4%
- Operating margin
- -1528.1%
- Segment
- U.S. government agencies: $2.134 million, down 30.6% year over year from $3.074 million
- Segment
- Commercial and non-U.S. government customers: $60 thousand, up 81.8% year over year from $33 thousand
What they said about what is next.
No numeric revenue or EPS guidance was provided. Management stated that initial customer deliveries are currently anticipated within the next year under the C-130J IDIQ production contract, with the first Merlin Pilot deployment planned within the next three years.
The filing reads worse than the one before it.
What came before.
- 10-Q · May 15, 2026
- Merlin Labs, Inc. reported revenue of $1,002 thousand for Q1 2026, a 15.4% increase from $868 thousand in Q1 2025. Despite revenue growth, the company incurred a net loss of $90,419 thousand, significantly higher than…
- 10-K · March 12, 2026
- Inflection Point Acquisition Corp. IV has transitioned from a blank check company into an impending merger with Merlin Labs, confirmed by a shareholder vote on March 12, 2026. With a total trust account investment of…
- 10-Q · November 12, 2025
- For Q3 2025, MRLN reported a net income of $83,694 driven by interest income, marking an improvement from a net loss of $47,447 in Q3 2024. The company continues to prepare for its merger with Merlin Labs, with $259.73…
- 10-Q · August 8, 2025
- For Q2 2025, MRLN reported a net income of $2,308,843, driven primarily by interest earned on investments. The company continues to operate without generating revenue or significant operational activities, as it…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing MRLN makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever